The use of technology to assist in care and its effects on quality and costs have been a source of continuing disappointment. Remote monitoring of chronic disease patients has a fairly long history, with uneven results. A new study in the Journal of the American Medical Association suggests that at least one approach to remote monitoring may improve the care of people with hypertension. (JAMA Article) Hypertension is widespread among US adults and while it can be controlled with diet, exercise and inexpensive drugs, physicians have had difficulty keeping patients’ blood pressure in the desired range. Uncontrolled hypertension can lead to adverse events and health care utilization. In a trial conducted at HealthPartners, some patients were remotely monitored and received consulting from trained pharmacists. The pharmacists conducted regular phone visits and emphasized lifestyle changes and medication adherence. At six and 12 months, 57% of the study group had controlled blood pressure versus only 30% in the usual care group. This effect appeared to be maintained for at least 6 months following the end of the study. More drugs were prescribed for the study group and they reported higher adherence to the medication regimen. The cost of the intervention was about $1350 per patient per year. The researchers did not report outcomes related to utilization or cost, but it is highly possible that the intervention group had lower total health spending if their blood pressure was in significantly better control.
Telemonitoring Aids in Blood Pressure Control
By Kevin RocheJuly 9, 2013Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
March 27, 2023
Why You Can’t Trust People Who Make Up Stuff About Vax Safety
A couple of studies offer a far better explanation for heart issues in athletes and…
March 25, 2023
Coronamonomania Lives Forever, Part 201
Tired of March Madness? A boringly refreshing dip into some CV-19 research summaries is recommended.
March 24, 2023
The CDC Is a Font of Methodological and Statistical Error
Several times in the last three years I and others have pointed out serious flaws…